The binding of epidermal growth factor (EGF) to its receptor induces tyrosine phosphorylation of phospholipase Cy (PLC-y), which appears to be necessary for its activation leading to phosphatidyl inositol (PI) hydrolysis. Moreover, EGF-receptor (EGF-R) 
Introduction
Serum growth factors stimulate cell growth and differentiation by binding to and activating cell surface receptors that possess intrinsic, ligandsensitive, protein tyrosine kinase activities. These surface receptors contain multiple functional domains including extracellular ligandbinding domain, transmembrane spanning region, catalytic tyrosine kinase domain, and flanking regularity sequences (reviewed by Ullrich and Schlessinger, 1990) . It has been recently appreciated that specific sequences containing tyrosine phosphorylation sites of growth factor receptors are binding sites for target proteins containing a sequence motif termed SH2 (src homology-2) (reviewed by Pawson, 1988) . These include PP60C-Src, phospholipase Cy (PLCy), GTPase activating protein (GAP), v-crk, and the phosphatidyl inositol (Pl)-3 kinase associated P85 protein Margolis et al., 1990a; Moran et al., 1990; Skolnik et al., 1991) .
The carboxy-terminal regions are among the most divergent sequences of all known receptor tyrosine kinases and also contain multiple tyrosine autophosphorylation sites (reviewed in Ullrich and Schlessinger, 1990) . The major tyrosine autophosphorylation sites of epidermal growth factor (EGF)-receptor (EGF-R) are clustered in the carboxy-terminal tail at positions Y1086 (Hsuan et al., 1989; Margolis et al., 1989a) , Y1068, Y1148, and Y1173 (Downward et al., 1985 . Although the regulatory role of autophosphorylation has been demonstrated in some tyrosine kinases, for example PP60c-src (Kmiecik and Shalloway, 1987; Piwnica-Worms et al., 1987) or insulin receptor (Rosen et al., 1983) , no profound and consistent role of EGF-R autophosphorylation has been established. Single mutations, from tyrosine to phenylalanine, of individual tyrosine autophosphorylation sites at positions Y1068, Y1 148, or Y1 173 did not have a major effect on EGF-R-mediated cellular responses (Honegger et al., 1988a,b) . It has been reported that truncation of 34 carboxyterminal amino acids, containing Y1 173, enhanced cell transformation (Khazaie et al., 1988) . However pacity in erythroblasts but not in fibroblasts (Khazaie et aL, 1988) . It was reported that larger carboxy-terminal truncations from residue 1052 to 957 resulted in enhanced protein tyrosine phosphorylation in NIH-3T3 cells (Chen et al., 1989) , suggesting that the carboxy-terminus plays an inhibitory role in the regulation of receptor tyrosine kinase activity. However, mutant receptors with shorter deletion of 19, 63, or 64 amino acid residues were less efficient than wild-type EGF-R in induction of EGF-dependent transformation and anchorage-independent growth of either 3T3 or RAT1 cells (Haley et al., 1988; Velu et aL, 1989 Figure  1 ), 1 x 106 receptors/cell (CD126/D2), or 1.2 x 1 06 receptors/cell (CD1 26/D4) (data not shown).
The capacity to stimulate phosphatidyl-inositol-4,5-phosphate (PIP2) breakdown by phospholipase C in response to EGF was also reduced in cells expressing the deletion mutants, served for the thymidine incorporation results of the various cell lines, the overall trend indicated the CD63 and CD126 were less responsive to EGF than HER14 cells. However, HER14, CD63, and CD1 26 were similarly responsive to 10% fetal calf serum. Figure 5 , A and B shows that the ability of EGF to induce thymidine incorporation and cell proliferation is severely reduced in CD63 and CD126 cells.
Discussion
The carboxy-terminal tails of growth factor receptors with tyrosine kinase activity are thought to function as regulatory regions. Hence, several reports describe the analysis of EGF-R mutants with altered carboxy-terminal tails. These include point mutations (Bertics et al., 1988; Honegger et al., 1988a,b) or various deletion mutants (Haley et al., 1988; Khazaie et al., 1988; Velu et al., 1989) . Nevertheless, the conclusions drawn from these analyses are inconsistent and confusing. Whereas certain studies suggest that the carboxy-terminal tail has an autoinhibitory function (Bertics et al., 1988; Honegger et al., 1988a,b; Chen et al., 1989) other studies support the view that this region has a stimulatory role in cell growth and transformation (Downward et al., 1984) .
Recent studies indicate that growth factors such as platelet-derived growth factor, EGF or fibroblast growth factor are able to stimulate tyrosine phosphorylation of PLC-'y (Margolis et al., 1989a,b; Meisenhelder et al., 1989; Wahl et al., 1988; Burgess et al., 1990) and that tyrosine phosphorylation activates the enzyme (Margolis et al., 1990a; Nishibe et al., 1990; Kim et aL, 1991) leading to enhanced Pi hydrolysis. We have recently shown that the tyrosine phosphorylated carboxy-terminal tail of EGF-R is a major site for association with PLCy and other SH2-containing proteins such as GAP and P13 kinase associated P85 (Margolis et al., 1990a; Skolnik et al., 1991) . Consistent with this view is the result shown in this report that EGF failed to induce Pi turnover and Ca2' release in cells expressing CD126; a mutant receptor lacking 126 carboxy-terminal residues including four tyrosine autophosphorylation sites. We have interpreted these results as an indication that deletion of the carboxy-terminal region prevented association with and tyrosine phosphorylation of PLCy, which therefore could not be activated, thus preventing EGF-induced PIP2 hydrolysis. This simple explanation is apparently incorrect as we show in this report that EGF is able to stimulate tyrosine phosphorylation of PLCy, bind avidly to the tyrosine phosphorylated tail, increasing the affinity of PLC-y toward the activated EGF-R and therefore decreasing the Km for tyrosine phosphorylation of PLCy. The carboxy-terminal tail of EGF-R has opposing functions: on one hand it directs interactions with SH2 containing target substrates and on the other hand it provides an autoinhibitory function for substrate phosphorylation. The balance between these two functions could play an important role in the physiological regulation of substrate recognition and phosphorylation. Truncation of the carboxy-terminal tail of EGF-R will remove both constraints and therefore as a net result the extent of tyrosine phosphorylation of PLCy may be marginally influenced in CD1 26 as compared with HER1 4 cells.
Recent evidence provide support for the view that growth factor-induced tyrosine phosphorylation of PLCy is essential for its activation leading (Nishibe et al., 1990; Kim et al., 1991) to PIP2 hydrolysis. Moreover, there is evidence that tyrosine phosphorylation does not directly enhance phospholipase C activity but rather releases an inhibitory constraint (Kim et al., 1991) . The nature of this inhibitory factor is not established nor is it clear whether it is tyrosine phosphorylated or able to interact with the carboxyterminal tail of EGF-R.
In addition, it is possible that PLCy is able to interact with EGF-R through unknown linker proteins that bind to region(s) on the EGF-R molecule other than the carboxy-terminal tail. An additional possibility is that the association calf serum (upper right) between PLCy and EGF-R and tyrosine phosphorylation of PLCy by EGF-R kinase are two unrelated phenomena. However, this explanation is unlikely because our preliminary results showed that the presence of SH2 domain decreases the Km for tyrosine phosphorylation for PLCy by the EGF-R kinase (Rotin et al., unpublished data) . Yet, it is clear that deletion in the carboxy-terminal tail have minor qualitative effect on the pattern of tyrosine phosphorylation of cellular substrates. The tyrosine phosphorylation of these as yet unknown substrates may play a role in regulation of different signaling pathways including Pi hydrolysis and Ca2' release.
Our results show that deletion of 63 amino acids from the carboxy-terminal tail has a profound effect on Ca2' release. This result in conflict with Chen et al. (1989) , who reported that an amino acid segment between residues 973 and 991 is critical for Ca2+ signaling. Our results are inconsistent with the notion that EGF-R has a specific Ca2" regulatory domain. Moreover, we did not detect a major increase in the total tyrosine phosphorylation of total cellular proteins in cells expressing carboxy-terminal deletion mutants (Chen et al., 1989) . The reason for these discrepancies are not known.
It is clear, however, that the carboxy-terminal tail has a profound effect on EGF-induced DNA synthesis. Yet, on the basis of our current knowledge it is impossible to correlate between the effects of carboxy-terminal deletion on early events and the reduced mitogenic activity. Nevertheless, this analysis provides further support for the central, yet not fully understood, role of the carboxy-terminal tail in regulation of receptor action.
Material and methods
NIH-3T3 cells expressing wt human EGF receptor (HER14) or carboxy-terminal truncation mutants (CD63 and CD126) were previously described (Margolis et al., 1989 sulfonylfluoride, 5MgM ZnCI2, 1 % Triton X-1 00, pH 7.1) (1 ml per 60-mm dish; 1.5 ml per 1 00-mm dish). Insoluble material was removed from lysates by centrifugation (14 000 rpm, 25 min, 40C in Eppendorf Centrifuge; Brinkmann Instruments, Germany). Protein concentrations were determined by the method of Bradford (1976) , and the total protein content of each lysate matched before immunoprecipitation. Isolation of phosphotyrosyl proteins by aPY antibody affinity chromatography was done as described (Li et al., 1991) . The aPY-reactive EGF-Rs and PLCy were isolated by a secondary immunoprecipitation of the aPY-reactive fractions with either anti-EGF-R antibody or anti-PLC-y antiserum. The total aPY-reactive proteins or the secondary immunoprecipitates were boiled for 5 min in electrophoresis sample buffer in the presence of 0.1 M f,-mercaptoethanol and subjected to gradient (7-15% acrylamide) SDS-PAGE at constant voltage (120 V) at 150C. 
